Telix Pharmaceuticals Limited Stock Analysis

Telix Stock Analysis Notes

The company had not issued any dividends in recent years. Telix Pharmaceuticals had 1:1000 split on the 29th of October 2013. To find out more about Telix Pharmaceuticals Limited contact the company at 61 3 9093 3855 or learn more at https://telixpharma.com.

Telix Pharmaceuticals Investment Alerts

Telix Largest EPS Surprises

View All Earnings Estimates

Telix Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Telix Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 3.28 B.

Telix Profitablity

The company has Net Profit Margin of 0.02 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average.

Management Efficiency

Telix Pharmaceuticals has Return on Asset of 0.0208 % which means that on every $100 spent on assets, it made $0.0208 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0314 %, implying that it generated $0.0314 on every 100 dollars invested. Telix Pharmaceuticals' management efficiency ratios could be used to measure how well Telix Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.05 in 2026. Return On Capital Employed is likely to rise to 0.07 in 2026. At this time, Telix Pharmaceuticals' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 721.9 M in 2026, whereas Other Current Assets are likely to drop slightly above 7.1 M in 2026.

Technical Drivers

As of the 14th of February 2026, Telix Pharmaceuticals has the Risk Adjusted Performance of (0.16), variance of 9.02, and Coefficient Of Variation of (493.40). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Telix Pharmaceuticals, as well as the relationship between them.

Telix Pharmaceuticals Price Movement Analysis

Telix Pharmaceuticals Insider Trading Activities

Telix Pharmaceuticals Outstanding Bonds

Telix Pharmaceuticals Predictive Daily Indicators

Telix Pharmaceuticals Corporate Filings

Telix Pharmaceuticals Forecast Models

Telix Pharmaceuticals' time-series forecasting models are one of many Telix Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Telix Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Telix Pharmaceuticals Bond Ratings

Telix Pharmaceuticals Limited financial ratings play a critical role in determining how much Telix Pharmaceuticals have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Telix Pharmaceuticals' borrowing costs.

Telix Pharmaceuticals Common Stock Shares Outstanding Over Time

Telix Pharmaceuticals Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Telix Pharmaceuticals uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Telix Pharmaceuticals Debt Ratio

36.0

It appears slightly above 64% of Telix Pharmaceuticals' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Telix Pharmaceuticals' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Telix Pharmaceuticals, which in turn will lower the firm's financial flexibility.

Telix Pharmaceuticals Corporate Bonds Issued

Telix Net Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how Telix Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Telix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Telix Pharmaceuticals. By using and applying Telix Stock analysis, traders can create a robust methodology for identifying Telix entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Telix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Telix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Telix Pharmaceuticals Limited stock analysis indicators help investors evaluate how Telix Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Telix Pharmaceuticals shares will generate the highest return on investment. By understating and applying Telix Pharmaceuticals stock analysis, traders can identify Telix Pharmaceuticals position entry and exit signals to maximize returns.

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.